This inventor holds 1 USPTO granted patent. Top assignee: Promega Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Charles S G Pugh
Introduction
Charles S G Pugh is an accomplished inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the development of antitoxins. His work focuses on creating methods for producing avian verotoxin antitoxin, which has important implications for both human and animal health.
Latest Patents
Pugh holds a patent for "Methods for producing avian verotoxin antitoxin." This invention includes methods for generating neutralizing antitoxin directed against verotoxins. In preferred embodiments, the antitoxin is produced in avian species using soluble recombinant verotoxin proteins. The antitoxin is designed to be administrable in therapeutic amounts and may be in any form, such as a solid or in aqueous solution. These antitoxins are useful in treating humans and other animals intoxicated with bacterial toxins, as well as for preventive treatment and diagnostic assays to detect the presence of toxins in samples. He has 1 patent to his name.
Career Highlights
Pugh is associated with Promega Corporation, a leading company in the biotechnology sector. His work at Promega has allowed him to focus on innovative solutions that address critical health challenges. His expertise in producing antitoxins has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Pugh has collaborated with notable colleagues, including James Arthur Williams and Lisa Marie Byrne. These collaborations have further enhanced his research and development efforts in biotechnology.
Conclusion
Charles S G Pugh is a notable inventor whose work in producing avian verotoxin antitoxin has significant implications for health and safety. His contributions to biotechnology continue to pave the way for advancements in treatment and prevention of toxin-related illnesses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
